Pharmacovigilance_Market_will_Grow_at_a_CAGR_of_13%_by_2020_-_by_Market_Research_Engine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Pharmacovigilance</strong> <strong>Market</strong> <strong>will</strong> <strong>Grow</strong> <strong>at</strong> a <strong>CAGR</strong> <strong>of</strong> <strong>13%</strong> <strong>by</strong> <strong>2020</strong> -<br />
<strong>by</strong> <strong>Market</strong> <strong>Research</strong> <strong>Engine</strong><br />
New York, July 26: <strong>Market</strong> <strong>Research</strong> <strong>Engine</strong> has published a new report titled as<br />
“<strong>Pharmacovigilance</strong> <strong>Market</strong> (Phases <strong>of</strong> Drug Development: Preclinical Studies,<br />
Clinical Trial Phase I, II, III & IV or Post <strong>Market</strong>ing Surveillance; Type <strong>of</strong> Methods:<br />
Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous<br />
Reporting, Cohort Event Monitoring, & EHR Mining; Type <strong>of</strong> Service: In-House &<br />
Contract Outsourcing) - Global Industry Analysis, Size, Share, <strong>Grow</strong>th, Trends and<br />
Forecast, 2014 - <strong>2020</strong>”<br />
<strong>Pharmacovigilance</strong> is associ<strong>at</strong>ed with drug safety which involves g<strong>at</strong>hering, detecting,<br />
monitoring and preventing adverse reaction <strong>of</strong> drug. It mainly focuses on adverse drug<br />
reactions. The inform<strong>at</strong>ion accumul<strong>at</strong>ed from healthcare providers and p<strong>at</strong>ients plays a<br />
significant role in pharmacovigilance to transpire. The whole purpose <strong>of</strong> pharmacovigilance<br />
is to minimize the adverse effects <strong>of</strong> drugs on the p<strong>at</strong>ients.<br />
Browse Full Report:<br />
https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market<br />
Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue <strong>of</strong> this<br />
market is projected to increase <strong>at</strong> <strong>CAGR</strong> <strong>of</strong> <strong>13%</strong> during the forecast period.North America is<br />
the leading market for pharmacovigilance market globally with largest market 2014. Europe<br />
is a subsequent market owing to implement<strong>at</strong>ion <strong>of</strong> pharmacovigilance. Asia Pacific market<br />
is fastest growing market with highest <strong>CAGR</strong> accounted in 2014.<br />
Increasing need <strong>of</strong> pharmacovigilance owing to increasing prevalence <strong>of</strong> adverse drug<br />
reaction is a major driving factor.Rise in intricacy <strong>of</strong> drug safety regul<strong>at</strong>ion <strong>by</strong> government is<br />
a growth factor for this market. <strong>Grow</strong>ing demand in paints & co<strong>at</strong>ing industry is one <strong>of</strong> the<br />
driving factor.<br />
The global pharmacovigilance market according to clinical trial phase is segmented aspreclinical,<br />
Phase I, Phase II, Phase IIIandPhase IV. The type <strong>of</strong> service provider segment<br />
consists <strong>of</strong> In-House and contract outsourcing. The market segments in terms <strong>of</strong><br />
geographical regions include North America, Europe, Asia-Pacific andRest <strong>of</strong> the<br />
World(ROW).<br />
This report provides:<br />
1) An overview <strong>of</strong> the global market for pharmacovigilance and rel<strong>at</strong>ed technologies.<br />
2) Analyses <strong>of</strong> global market trends, with d<strong>at</strong>a from 2013, estim<strong>at</strong>es for 2014 and 2015,<br />
and projections <strong>of</strong> compound annual growth r<strong>at</strong>es (<strong>CAGR</strong>s) through <strong>2020</strong>.<br />
3) Identific<strong>at</strong>ions <strong>of</strong> new market opportunities and targeted promotional plans for<br />
pharmacovigilance market.<br />
4) Discussion <strong>of</strong> research and development, and the demand for new products and new<br />
applic<strong>at</strong>ions.
5) Comprehensive company pr<strong>of</strong>iles <strong>of</strong> major players in the industry.<br />
REPORT SCOPE:<br />
The scope <strong>of</strong> the report includes a detailed study <strong>of</strong> global and regional markets for various<br />
types <strong>of</strong> co<strong>at</strong>ings with the reasons given for vari<strong>at</strong>ions in the growth <strong>of</strong> the industry in<br />
certain regions.<br />
The report covers detailed competitive outlook including the market share and company<br />
pr<strong>of</strong>iles <strong>of</strong> the key participants oper<strong>at</strong>ing in the global market.<br />
Key players pr<strong>of</strong>iled in the report include:<br />
• Quintiles Transn<strong>at</strong>ional Corpor<strong>at</strong>ion<br />
• Accenture Plc.<br />
• Boehringer Ingelheim GmbH<br />
• Bristol-Myers Squibb<br />
• PAREXEL Intern<strong>at</strong>ional Corpor<strong>at</strong>ion<br />
• Janssen <strong>Research</strong> & Development LLC<br />
• Pharmaceutical Product Development Inc.<br />
• United BioSource Corpor<strong>at</strong>ion<br />
• Synowlwedge LLC<br />
• Cognizant Technology Solutions Corpor<strong>at</strong>ion<br />
• Covance Inc.<br />
• ICON, Plc.<br />
Company pr<strong>of</strong>ile includes assign such as company summary, financial summary, business<br />
str<strong>at</strong>egy and planning, SWOT analysis and current developments.<br />
The Top Companies Report is intended to provide our buyers with a snapshot <strong>of</strong> the<br />
industry’s most influential players.<br />
The <strong>Pharmacovigilance</strong> <strong>Market</strong> has been segmented as below:<br />
<strong>by</strong> Clinical Trial Phase<br />
• Pre clinical<br />
• Phase I<br />
• Phase II<br />
• Phase III<br />
• Phase IV<br />
<strong>by</strong> Type <strong>of</strong> Service Provider<br />
• In- House<br />
• Contract outsourcing<br />
<strong>by</strong> Region<br />
• North America<br />
• Europe<br />
• Asia Pacific<br />
• Rest <strong>of</strong> the World (RoW)<br />
Reasons to buy this Report:<br />
1) Obtains the most up to d<strong>at</strong>e inform<strong>at</strong>ion available on all active and planned<br />
pharmacovigilance industry globally.<br />
2) Identify growth segments and opportunities in the industry.<br />
3) Facilit<strong>at</strong>e decision making on the basis <strong>of</strong> strong historic and forecast <strong>of</strong><br />
pharmacovigilance industry and unit capacity d<strong>at</strong>a.<br />
4) Assess your competitor’s refining portfolio and its evolution.
Other <strong>Research</strong> Report:<br />
<br />
Magnesium Oxide Nanopowder <strong>Market</strong> for Furnaces & Boilers, Paints & Co<strong>at</strong>ings,<br />
Electronics, Electrical, Construction, and Other End-users - Global Industry Analysis,<br />
Size, Share, <strong>Grow</strong>th, Trends and Forecast 2015 - 2023<br />
https://www.marketresearchengine.com/reportdetails/magnesium-oxidenanopowder-market<br />
<br />
Specialty Enzymes <strong>Market</strong> - Global Industry Analysis, Size, Share, <strong>Grow</strong>th, Trends<br />
and Forecast, 2015 - <strong>2020</strong><br />
https://www.marketresearchengine.com/reportdetails/speciality-enzymes-market<br />
About <strong>Market</strong><strong>Research</strong><strong>Engine</strong>.com<br />
<strong>Market</strong> <strong>Research</strong> <strong>Engine</strong> is a global market research and consulting organiz<strong>at</strong>ion. We<br />
provide market intelligence in emerging, niche technologies and markets. Our market<br />
analysis powered <strong>by</strong> rigorous methodology and quality metrics provide inform<strong>at</strong>ion and<br />
forecasts across emerging markets, emerging technologies and emerging business models.<br />
Our deep focus on industry verticals and country reports help our clients to identify<br />
opportunities and develop business str<strong>at</strong>egies.<br />
Media Contact<br />
Company Name: <strong>Market</strong> <strong>Research</strong> <strong>Engine</strong><br />
Contact Person: John Bay<br />
Email: john@marketresearchengine.com<br />
Phone: +1-855-984-1862, +91-860-565-7204<br />
Country: United St<strong>at</strong>es<br />
Website: http://www.marketresearchengine.com/
Change language